Cargando…

Plasma Metabolite Biomarkers for the Detection of Pancreatic Cancer

[Image: see text] Patients with pancreatic cancer (PC) are usually diagnosed at late stages, when the disease is nearly incurable. Sensitive and specific markers are critical for supporting diagnostic and therapeutic strategies. The aim of this study was to use a metabonomics approach to identify po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Guoxiang, Lu, Lingeng, Qiu, Yunping, Ni, Quanxing, Zhang, Wei, Gao, Yu-Tang, Risch, Harvey A., Yu, Herbert, Jia, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324440/ https://www.ncbi.nlm.nih.gov/pubmed/25429707 http://dx.doi.org/10.1021/pr501135f

Ejemplares similares

Urinary Prostaglandin E(2) Metabolite and Pancreatic Cancer Risk: Case-Control Study in Urban Shanghai
por: Zhao, Jing, et al.
Publicado: (2015)

Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population
por: Xu, Hong-Li, et al.
Publicado: (2014)

Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome
por: Lu, Lingeng, et al.
Publicado: (2011)

Lowered circulating aspartate is a metabolic feature of human breast cancer
por: Xie, Guoxiang, et al.
Publicado: (2015)

Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer
por: Jin, Kaizhou, et al.
Publicado: (2015)

Machine learning-based cluster analysis of immune cell subtypes and breast cancer survival
por: Wang, Zhanwei, et al.
Publicado: (2023)

Joint Effect of Genotypic and Phenotypic Features of Reproductive Factors on Endometrial Cancer Risk
por: Wang, Zhanwei, et al.
Publicado: (2015)

Association of gut microbiota, plasma and fecal metabolite profiles with intellectual development in school-age children
por: Zhou, Yingyu, et al.
Publicado: (2023)

Editorial: Nonalcoholic fatty liver disease: From pathogenesis to phytomedicine based on omics technology
por: Ji, Guang, et al.
Publicado: (2022)

Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis
por: Wang, Zhanwei, et al.
Publicado: (2015)

Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles
por: Wang, Wei, et al.
Publicado: (2016)

Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma
por: Cao, Yingying, et al.
Publicado: (2022)

Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration
por: He, Jiaojiao, et al.
Publicado: (2015)

Effects of ADMA on gene expression and metabolism in serum-starved LoVo cells
por: Zheng, Ningning, et al.
Publicado: (2016)

Metabolic profiling reveals therapeutic effects of Herba Cistanches in an animal model of hydrocortisone-induced 'kidney-deficiency syndrome'
por: Qiu, Yunping, et al.
Publicado: (2008)

Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Meng, Qingcai, et al.
Publicado: (2017)

Glutamine deprivation induces ferroptosis in pancreatic cancer cells: Glutamine deprivation induces pancreatic cancer ferroptosis
por: Xiao, Zhiwen, et al.
Publicado: (2023)

Small molecule metabolites: discovery of biomarkers and therapeutic targets
por: Qiu, Shi, et al.
Publicado: (2023)

Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer
por: Shen, Yi, et al.
Publicado: (2015)

Randomized trial of exercise on cancer‐related blood biomarkers and survival in women with ovarian cancer
por: Cartmel, Brenda, et al.
Publicado: (2023)

Plasma metabolites as possible biomarkers for diagnosis of breast cancer
por: Park, Jiwon, et al.
Publicado: (2019)

Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer
por: Xiao, Zhiwen, et al.
Publicado: (2014)

Prognosis of distal pancreatic cancers controlled by stage
por: Luo, Guopei, et al.
Publicado: (2020)

Biomarker Metabolites Discriminate between Physiological States of Field, Cave and White-nose Syndrome Diseased Bats
por: Doty, Anna C., et al.
Publicado: (2022)

Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer
por: Li, Le, et al.
Publicado: (2016)

Esophageal Cancer Metabolite Biomarkers Detected by LC-MS and NMR Methods
por: Zhang, Jian, et al.
Publicado: (2012)

Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
por: Hua, Jie, et al.
Publicado: (2018)

GPx1 is involved in the induction of protective autophagy in pancreatic cancer cells in response to glucose deprivation
por: Meng, Qingcai, et al.
Publicado: (2018)

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2020)

Lewis antigen-negative pancreatic cancer: An aggressive subgroup
por: Liu, Chen, et al.
Publicado: (2020)

Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection
por: Moon, Jee-Young, et al.
Publicado: (2018)

Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study
por: Skubisz, Karolina, et al.
Publicado: (2023)

Prognostic value of γ‐glutamyltransferase‐to‐albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery
por: Li, Shuo, et al.
Publicado: (2019)

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
por: Mori, Akio, et al.
Publicado: (2019)

Potential Plasma Metabolite Biomarkers of Diabetic Nephropathy: Untargeted Metabolomics Study
por: Trifonova, Oxana P., et al.
Publicado: (2022)

Characterization of Salivary and Plasma Metabolites as Biomarkers for HCC: A Pilot Study
por: Hershberger, Courtney E., et al.
Publicado: (2023)

Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer: A meta-analysis up to now
por: Wei, Lunshou, et al.
Publicado: (2018)

Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysis
por: Zhang, Yiyin, et al.
Publicado: (2019)

Plasma metabolite profiling reveals potential biomarkers of giant cell tumor of bone by using NMR-based metabolic profiles: A cross-sectional study
por: Wang, Wei, et al.
Publicado: (2019)

Bifidobacterium spp. and their metabolite lactate protect against acute pancreatitis via inhibition of pancreatic and systemic inflammatory responses
por: Li, Han, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a964fhbc7206imqsu7hlhmkmnc